Omega Healthcare initiated with a Market Perform at BMO Capital

BMO Capital analyst Juan Sanabria initiated coverage of Omega Healthcare with a Market Perform rating and $34.50 price target. With the shares up 15% year-to-date, the analyst believes the company’s increased stability and growth is already priced in. Omega’s relative multiple is higher versus peers than historically, which limits the upside in the shares, the analyst tells investors in a research note.